Advertisements

Амлодипин

Quick links to important sections

Амлодипин

Selected form

Advertisements
Advertisements

Treatment option: Hypertension, Angina Pectoris

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Амлодипин

Property Description
Active ingredient Amlodipine (often as besylate salt)
Form Oral tablets, solution, or suspension
Pharmacological class Calcium Channel Blocker (Dihydropyridine)
Common use Maintaining healthy blood pressure and preventing angina
Origin Synthetic small molecule

What Type of Medicine is Амлодипин?

Амлодипин (Amlodipine) is a synthetic small molecule prescription-only medicine that is structurally derived from dihydropyridine. It is clinically recognized for its long duration of action, allowing for once-daily dosing. It is classified pharmacologically as a Calcium Channel Blocker (CCB). This class places Amlodipine among key agents for managing cardiovascular conditions, primarily defining it as an antihypertensive agent and a long-acting antianginal agent. Amlodipine is used to decrease blood pressure and prevent chest pain. The medicine serves a dual purpose in supporting the heart and circulatory system.


Амлодипин: Active Ingredient and Preparation Form

The active ingredient is Amlodipine, which is stabilized for formulation, most commonly as its salt, Amlodipine besylate. This agent is typically supplied for oral administration in various oral dosage forms, including standard tablets, as well as commercially available oral solution and oral suspension forms. The flexibility in formulation is key for patient groups who may have difficulty swallowing. Amlodipine is often used as a single-ingredient product (monotherapy), though it is also a component in various combination products designed to address complex therapeutic requirements. Popular brands containing this INN include Norvasc and Katerzia.


What is the General Purpose of Амлодипин?

The general purpose of Амлодипин is to promote the relaxation and widening of the arteries throughout the body, a key action when treating high pressure in adults. The drug acts as a calcium ion antagonist, a mechanism that inhibits the entry of calcium ions into the vascular smooth muscle cells. This action, known as vasodilation, directly reduces the mechanical resistance that blood vessels exert on circulation, thereby sustaining lower blood pressure and ensuring better coronary blood flow. Amlodipine reduces peripheral resistance and is utilized for its vasodilation action. This function improves the ease with which blood flows through the body. Its overall function is to reduce peripheral vascular resistance, providing therapeutic benefits in conditions related to high pressure and insufficient oxygen supply to the heart.

Regulatory References

  1. WHO Essential Medicines List (EML)
Advertisements

What side effects are possible with Амлодипин?

Possible side effects and safety information

The officially documented safety profile of Amlodipine is structured by governmental regulatory agencies using classification tiers to describe the likelihood and type of adverse reactions.


Frequency-Classified Adverse Reactions

Adverse reactions are grouped by the estimated frequency of their occurrence, based on official regulatory data:

  • Very Common (ge 1/10): Edema (swelling), which is recognized as a dose-related effect.
  • Common (ge 1/100 to < 1/10): Headache, Dizziness, Somnolence (drowsiness), Palpitations, Flushing, Abdominal pain, Nausea, and Fatigue.
  • Very Rare (< 1/10,000): Hepatitis, Pancreatitis, severe skin reactions like Angioedema, and the reported event of Myocardial infarction.

These effects are formally categorized into System-Organ Classes (SOCs), including Vascular Disorders, Nervous System Disorders, and Gastrointestinal Disorders.


Safety Patterns and Special Populations

Certain safety patterns are explicitly noted in regulatory documents. Some effects, such as dizziness and somnolence, are officially documented as being more frequent at the start of treatment. The profile notes that caution is required when used in elderly patients and individuals with hepatic impairment, as reduced drug clearance in these groups may result in increased systemic exposure. Official documentation also contains specific safety restrictions; for instance, the medicine is generally not used in individuals with severe hypotension or cardiogenic shock.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The following information is based strictly on authoritative government regulatory sources detailing the documented manifestations and emergency actions for Amlodipine overdose.


Overdose Scope

Domain Official Regulatory Statements
Documented overdose presentations Profound and prolonged systemic hypotension is the expected primary manifestation, resulting from excessive peripheral vasodilation. Other signs may include reflex tachycardia or bradycardia, dizziness, somnolence, and confusion.
Physiological systems affected Primarily the cardiovascular system (hypotension, shock) and the central nervous system (dizziness, somnolence).
Exposure-related factors Large doses or co-ingestion with other cardioactive drugs increase the risk of a severe outcome, which can include multi-organ failure.
Population-specific overdose notes Increased risk of severe outcome is noted for patients of advanced age and those with preexisting cardiac impairment.
Emergency-response statements Immediate medical attention is required. Contact a Poison Control Center or emergency services right away, even if symptoms are not yet present.

Overdose Classifications (High-Level)

Classification Official Regulatory Statements
Severity classification The event is officially described as potentially leading to shock and death.
Overdose-context constraints No specific antidote is known. Hemodialysis is not likely to be beneficial due to high protein binding.

Official Overdose Statements:

  • The primary clinical manifestation is prolonged systemic hypotension.
  • Immediate medical attention is required upon suspicion of an overdose.
  • Active cardiac and respiratory monitoring must be initiated, alongside frequent blood pressure measurements.
  • Supportive measures include conservative steps like elevation of the extremities, judicious administration of fluids, and the use of vasopressors if hypotension persists.

Connection to the overall overdose profile: Regulatory documents define the overdose profile around the severe risk of hemodynamic instability, which progresses to potentially fatal circulatory collapse or shock. This officially documented risk mandates that individuals seek medical help right away, initiating the supportive care and intensive monitoring procedures detailed in the prescribing information, in light of the documented absence of a specific pharmacological antidote.

Advertisements

Therapeutic Uses of Амлодипин

What Амлодипин Treats: Main Uses and Benefits

Amlodipine (Амлодипин) is generally utilized across key therapeutic domains to provide supportive management and symptomatic relief for major cardiovascular conditions. Its purpose is to address clinical presentations of symptoms related to systemic imbalance and symptoms linked to restricted blood flow, offering long-term supportive benefit. The medicine is utilized for high blood pressure (Hypertension), specific types of chest pain (Angina Pectoris), and the management of conditions arising from Coronary Artery Disease.

The medicine is relevant across therapeutic domains involving chronic conditions marked by increased physiological stress, where supportive management is appropriate. It helps address symptom clusters that may become intense or disruptive, such as sustained pressure elevation and exertional or rest-induced chest discomfort. This offers symptomatic relief that supports patients during difficult episodes and assists with maintaining comfort.


Quick Fact: Symptomatic Relief

Amlodipine is used for the prophylaxis of angina, is used for managing symptoms like sternal heaviness and chest pressure, and supports general well-being.

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Amlodipine

The eligibility profile for Amlodipine is strictly defined by regulatory documentation concerning population restrictions and contraindications.

Absolute Contraindications

Use is prohibited for patients with known hypersensitivity to amlodipine or other dihydropyridine derivatives. The medicine is also contraindicated in patients with severe hypotension (very low blood pressure), cardiogenic shock, and obstruction of the left ventricular outflow tract (such as high-grade aortic stenosis).

Age- and Condition-Based Restrictions

Adults are eligible for use across all approved indications. In the pediatric population, Amlodipine use is established only for patients aged 6 to 17 years treating hypertension; use is not established for children under six years old. Caution is advised for older adults and patients with hepatic impairment, as reduced drug clearance may require the dose to be started at the low end of the therapeutic range. Caution is also advised for patients with heart failure.

Life-Stage Limitations

Regulatory guidance states that use during pregnancy is restricted to circumstances where the potential benefit justifies the risk. Nursing mothers are generally advised to discontinue nursing while receiving this medication, as it is unknown if the drug is excreted in human milk.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Amlodipine can interact with other medicinal products by affecting the body's processing of either amlodipine or the co-administered drug. The primary basis for these interactions is amlodipine's metabolism via the Cytochrome P450 3A4 (CYP3A4) enzyme pathway.

Documented Interaction Categories

Interacting Product Category Mechanistic Effect on Amlodipine/Co-drug
CYP3A4 Inhibitors (e.g., ketoconazole, ritonavir) Increase amlodipine plasma concentrations, potentially leading to increased exposure. Dose adjustment of amlodipine may be necessary.
CYP3A4 Inducers (e.g., rifampicin) May decrease amlodipine plasma concentrations, potentially reducing its therapeutic effect.
HMG-CoA Reductase Inhibitors (Statins) Amlodipine increases exposure to certain statins by inhibiting CYP3A4.

Specific Restrictions and Constraints

The most clinically significant restriction involves the co-administration of simvastatin. Amlodipine is known to increase the systemic exposure of simvastatin, which is associated with an elevated risk of muscle toxicity (myopathy and rhabdomyolysis).

  • Simvastatin Restriction: The dose of simvastatin must not exceed 20 mg daily when used concomitantly with amlodipine.

When amlodipine is co-administered with other blood pressure-lowering agents such as thiazide diuretics, beta-blockers, or ACE inhibitors, the potential for additive effects resulting in lower blood pressure should be noted, although no routine dose adjustments for amlodipine itself are specified for these combinations. The interaction profile is managed through dosage limitations for specific co-administered drugs and careful monitoring when combining with substances that strongly affect CYP3A4 activity.

Advertisements

Mechanism of Action

Targeting Voltage-Dependent Calcium Channels

Amlodipine's mechanism involves selective interference with calcium signaling pathways, resulting in a reduction in mechanical resistance throughout the circulatory system. The drug functions as a calcium ion entry blocker by binding to the L-type voltage-dependent calcium channel (Cav1.2) found primarily in the cell membranes of vascular smooth muscle. This binding is characterized by a slow rate of association and dissociation from the channel, which supports a prolonged duration of blockade.

The Cascade of Vascular Smooth Muscle Relaxation

By inhibiting the flow of extracellular calcium ions (Ca^2+) into the smooth muscle cell, the drug suppresses the internal signaling required for muscle contraction. This molecular action triggers a cascade resulting in the widespread relaxation (vasodilation) of the arterial walls, modulating the muscle tone and decreasing resistance in the peripheral circulation.

Reducing Systemic Peripheral Resistance

The resulting arteriolar vasodilation leads to a sustained reduction in Systemic Peripheral Vascular Resistance (SVR). This physiological consequence directly lowers the afterload—the mechanical resistance the heart must pump against—which modulates systemic pressure dynamics and influences the heart's mechanical effort.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Амлодипин


Administration Scope

Usage Parameter Instruction
Route of Administration Oral route only, available as tablets (2.5 mg, 5 mg, 10 mg) and various liquid formulations.
Dosing Schedule (Adults) The typical initial dose is 5 mg once daily, with a maximum dose of 10 mg once daily.
Timing in Relation to Meals May be taken with or without food, but administration should occur at approximately the same time each day.
Preparation Requirements Liquid formulations (solutions or suspensions) must be measured with a dedicated device, and some powdered forms require specific mixing instructions to ensure the full dose is consumed.
Age-Group Rules The pediatric dose (ages 6–17 for hypertension) starts at 2.5 mg once daily, with a maximum dose of 5 mg once daily.
Missed-Dose Rules If a dose is forgotten, it should be skipped if it is almost time for the next scheduled dose; do not take a double dose.

Special Procedural Conditions

  • Titration Interval: Dosage adjustments generally proceed slowly, waiting 7 to 14 days between dose increases to assess the established therapeutic level.
  • Population Adjustments: A lower initial dose (e.g., 2.5 mg) is recommended for older adults and patients with hepatic impairment.
  • Dietary Constraint: The consumption of grapefruit or grapefruit juice should be avoided.

Connection to the Overall Use Protocol

The oral, once-daily frequency is the fundamental pattern for administration, supporting continuous management. The specified starting doses, maintenance range, and 7–14 day titration interval describe the procedural approach used for treatment initiation and dose progression. The use of lower starting doses for specific populations ensures cautious use.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Амлодипин

Evidence for use in Hypertension (High Blood Pressure)

Амлодипин was studied for its use in high blood pressure. The research primarily involved large-scale, long-term randomized controlled trials (RCTs), which were conducted across diverse adult populations, including older individuals and those with existing health issues like kidney conditions.

Researchers monitored changes in both systolic and diastolic blood pressure measurements. The large-scale trials also explored long-term outcomes, tracking the occurrence of major cardiovascular events, such as stroke or heart attack, over extended time intervals. Findings describe patterns where measured blood pressure outcomes were reported over intermediate-term observation periods.

Evidence for use in Chronic Stable Angina

Research examined Амлодипин's application in chronic stable angina. Studies exploring this use primarily consisted of short-to-intermediate-term, placebo-controlled trials. These trials monitored outcomes reflecting daily functioning and activity level, tracking the reported frequency of angina episodes and changes in exercise tolerance time.

What remains uncertain is that the evidence for this indication is largely focused on monitoring symptoms and functional ability; fewer studies are specifically designed to examine major cardiac event reduction in this population compared to the hypertension research. Follow-up durations were limited in many of these trials, and limited information is available for long-term outcomes regarding symptom patterns.

Long-Term Studies and Follow-up Duration

Studies have explored the long-term application of Амлодипин, with some trials monitoring patients for multiple years to track the measurement of outcomes. This research describes the observed durability of blood pressure changes and provides context on cardiovascular event rates over defined time intervals. However, long-term effects spanning decades of use are not fully established for all patient groups.

What is Still Uncertain About Амлодипин Research

Research provides context but not individual predictions, and evidence highlights what is known and what is still uncertain. Data for certain high-risk groups remain insufficient, and comparative evidence is lacking for certain newer medications and combinations.

Key Studies & References

  1. Impact of amlodipine on clinical outcomes for heart failure in patients with dilated cardiomyopathy: a Korean nationwide cohort study - Frontiers (Observational data on long-term CV outcomes)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Амлодипин (FAQ)

Q: Are there official dietary restrictions when taking Amlodipine?

Official product information states that large amounts of grapefruit or grapefruit juice should be avoided. This is because grapefruit may increase the concentration of the drug in the body and potentially strengthen its effects. Beyond this specific interaction, patients generally do not have other specific dietary restrictions documented in the product label.


Q: How long does it take for Amlodipine to reach its full effect?

Because Amlodipine is a long-acting drug, it takes time for the medication to build up to a consistent level in the body. According to regulatory pharmacokinetic data, the maximum therapeutic concentration (known as the steady state) is typically observed after 7 to 14 days of continuous daily dosing.


Q: How does Amlodipine affect blood cholesterol levels?

Official reports from clinical trials did not indicate clinically significant changes in routine blood tests, including levels of total cholesterol, HDL-cholesterol, or triglycerides. The product information is primarily focused on the drug’s intended purpose of managing blood pressure and angina.


Q: Is Amlodipine considered safe for the multi-year treatment of hypertension?

Amlodipine is widely used in the long-term management of both high blood pressure and chronic stable angina, and its long-term application has been studied in clinical trials. However, regulatory documents note that caution is required when prescribing the drug to specific patient groups, such as older adults or those with heart failure.


Q: Should Amlodipine be taken in the morning or in the evening?

Regulatory guidance notes the importance of taking the medication once daily at approximately the same time every day. This consistency is essential to maintain a stable level of the drug in the bloodstream. The specific time of day (morning or evening) is not typically mandated in the official instructions.


Q: What symptoms require immediate medical attention while taking Amlodipine?

The official safety information lists certain rare but serious reactions that require prompt medical care. Official safety information cites symptoms such as increased frequency or severity of chest pain, rapid or irregular heartbeat, fainting, or signs of liver problems such as jaundice (yellowing of the skin or eyes) or dark urine.


Q: Why is Amlodipine sometimes combined with Benazepril in a single tablet?

Combination products containing Amlodipine (a Calcium Channel Blocker) and Benazepril (an ACE Inhibitor) are used to treat high blood pressure through two distinct mechanisms simultaneously. This dual action is intended to provide a stronger overall reduction in pressure.


Q: Does Amlodipine help protect the kidneys in patients with hypertension?

The primary therapeutic action of Amlodipine is to reduce high blood pressure. Amlodipine's action in lowering blood pressure is associated with a reduction in the major risks associated with chronic hypertension, which includes damage to the blood vessels in the kidneys.


Q: How quickly does Amlodipine start working after the first dose?

Regulatory pharmacokinetic data indicates that following the first oral dose, the drug begins to gradually reduce blood pressure over a period of approximately 4 to 8 hours. The maximum concentration of the drug in the body is usually reached within 6 to 12 hours after ingestion.


Q: Can Amlodipine affect heart rate?

Official safety documents list palpitations (awareness of the heartbeat) as a common side effect of Amlodipine. Less frequently, changes to heart rhythm, known as arrhythmias, including both slower and faster heart rates, have been reported in official documents.


Q: Can Amlodipine be used by patients with diabetes?

Clinical trial data and official documentation confirm that Amlodipine is a well-established treatment for hypertension. It is routinely used to manage high blood pressure in patients who also have co-existing conditions, including diabetes.


Q: Is it possible to drive a car while taking Amlodipine?

Official product information states that Amlodipine may have a minor to moderate effect on the ability to drive or operate machinery. Official information states that caution may be necessary, particularly during the initial phase of treatment or when increasing the dose, if the patient experiences side effects such as dizziness, headache, or fatigue.


Q: Are there restrictions on consuming alcohol while taking Amlodipine?

Although regulatory documents do not prohibit alcohol use, regulatory documents note that caution may be necessary. Alcohol can further lower blood pressure, potentially increasing common side effects like dizziness or headache. Patients may wish to discuss appropriate alcohol consumption levels with a healthcare provider.


Q: What happens if you suddenly stop taking Amlodipine?

Regulatory guidance notes that sudden cessation of blood pressure medication is generally discouraged in clinical practice. Abruptly stopping treatment may lead to a rapid increase in blood pressure (known as rebound hypertension) or could potentially worsen existing symptoms of angina (chest pain).


Q: Are there known interactions between Amlodipine and over-the-counter painkillers?

According to drug interaction databases, the regular or long-term use of certain non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen or naproxen, may potentially weaken Amlodipine's blood pressure-lowering effect. Acetaminophen (paracetamol) is generally not known to interact in this way.


Q: Does Amlodipine affect blood sugar levels?

Hyperglycemia, which is the technical term for high blood sugar, is listed in the official documents as a very rare adverse reaction associated with Amlodipine use.


Q: Can Amlodipine cause weight gain?

Weight gain is not explicitly listed as a side effect in official regulatory documents. However, a very common side effect of the drug is edema (swelling), particularly in the ankles, which is often dose-related and may be perceived by patients as gaining weight.


Q: Is dose adjustment of Amlodipine required for kidney diseases?

Official product labels state that dose adjustment is generally not required for patients with renal impairment (kidney disease). This is because the concentration of Amlodipine in the bloodstream is not significantly altered by the severity of impaired kidney function.


Q: Can Amlodipine affect mood or cause anxiety?

Official safety information lists adverse reactions that relate to psychiatric disorders. Mood changes (including anxiety) and insomnia are reported as uncommon side effects, while confusion is documented as a rare event.


Q: Are there official warnings about exposure to heat or sun during treatment?

Patient information suggests that extra care may be appropriate during periods of hot weather or intense physical activity. Heavy sweating under these conditions is associated with the potential for the blood pressure to drop excessively low.

Advertisements

How should Амлодипин be stored and disposed of?

Official Storage and Disposal Instructions

Amlodipine tablets must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with storage limits required to be below 30 C. To maintain product quality and stability, the medication must be kept in the original, tightly closed, light-resistant container, stored away from light, moisture, and excess heat. Do not store the medicine in high-humidity areas, such as a bathroom.

Storage Requirement Official Condition
Temperature Controlled Room Temperature (Below 30 C)
Protection Store away from light and moisture
Safety Keep out of the sight and reach of children

Disposal of any unused or expired amlodipine must be carried out in accordance with local requirements. The medicine should not be flushed down the toilet or poured into a drain unless directed to do so by a government take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Амлодипин found in:

A-Z Index: